These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20096540)

  • 1. Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse.
    Poirier S; Legris G; Tremblay P; Michea R; Viau-Guay L; Mérette C; Bouchard RH; Maziade M; Roy MA
    Schizophr Res; 2010 May; 118(1-3):285-91. PubMed ID: 20096540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenic patients with polydipsia and water intoxication more often have a form of schizophrenia first described by Kraepelin.
    Bralet MC; Ton T; Falissard B
    Psychiatry Res; 2007 Aug; 152(2-3):267-71. PubMed ID: 17445907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
    Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom remission in first episode patients.
    Addington J; Addington D
    Schizophr Res; 2008 Dec; 106(2-3):281-5. PubMed ID: 18926666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
    Dixon L; Haas G; Weiden PJ; Sweeney J; Frances AJ
    Am J Psychiatry; 1991 Feb; 148(2):224-30. PubMed ID: 1987823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics influencing age at onset in psychotic disorders.
    Ongür D; Lin L; Cohen BM
    Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premorbid adjustment in schizophrenia and schizoaffective disorder.
    Saracco-Alvarez R; Rodríguez-Verdugo S; García-Anaya M; Fresán A
    Psychiatry Res; 2009 Feb; 165(3):234-40. PubMed ID: 19162333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences.
    Margolese HC; Malchy L; Negrete JC; Tempier R; Gill K
    Schizophr Res; 2004 Apr; 67(2-3):157-66. PubMed ID: 14984874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and depressive symptoms in first episode psychosis.
    Romm KL; Rossberg JI; Berg AO; Barrett EA; Faerden A; Agartz I; Andreassen OA; Melle I
    J Nerv Ment Dis; 2010 Jan; 198(1):67-71. PubMed ID: 20061872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures.
    Vares M; Ekholm A; Sedvall GC; Hall H; Jönsson EG
    Psychopathology; 2006; 39(6):286-95. PubMed ID: 16960467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-psychotic depression in schizophrenia.
    Chintalapudi M; Kulhara P; Avasthi A
    Eur Arch Psychiatry Clin Neurosci; 1993; 243(2):103-8. PubMed ID: 8218426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenomenology and diagnostic stability of youths with atypical psychotic symptoms.
    Hlastala SA; McClellan J
    J Child Adolesc Psychopharmacol; 2005 Jun; 15(3):497-509. PubMed ID: 16092913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlates, change and 'state or trait' properties of insight in schizophrenia.
    Wiffen BD; Rabinowitz J; Lex A; David AS
    Schizophr Res; 2010 Sep; 122(1-3):94-103. PubMed ID: 20382507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.